According to some experts 2015 could be an important year ever to fight
Alzheimer's disease. The Boston University Alzheimer's Disease Center and
Boston Medical Center will be involved in several studies, together with the
test to observe the effects of a drug known as T-817MA.
At present, just five drugs are approved to treat Alzheimer's disease. T-817MA is aimed at people who are already suffering from a degree of dementia, and it could probably change the course of Alzheimer's disease.
"In all the studies that are going on, this is one of the most, if not the most promising approach to try to slow down the disease in someone who is already at the point of having moderate stages of dementia," said Dr. Robert Stern, Director of the Alzheimer's Disease Center.